About Us

Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anemia.

Learn more

Shield-AboutUs-720-540.jpg

The content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.